Since the highly active anti-retroviral treatment (HAART) was introduced for acquired immunodeficiency syndrome (AIDS), the incidence of opportunistic infections has decreased and new pathogens, such as diarrheagenic Escherichia coli (DEC) groups, 1 are now associated with diarrhea in human immunodeficiency virus (HIV) patients. Because antibiotic therapy may be successful in cases where pathogenic bacteria are identified, studies focusing on bacterial diarrhea in AIDS patients are needed. The DECs have been classified into six groups based on specific genes that determine their virulence factors: enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), Shiga toxin producing E. coli (STEC), enteroagregative E. coli (EAEC), enteropathogen E. coli (EPEC), and diffusely adherent E. coli (DAEC). 2 The role of different DECs in causing diarrhea in HIV-infected people in Latin American countries has not been adequately addressed because most studies have not examined for all currently recognized groups of DECs. Our objective was to characterize the different DECs in stools from adult HIV patients in Lima, Perú. 3, 4 This PCR has a sensitivity of 99% and a specificity of 100% 3 and has been previously validated in our laboratory. 4 Stools were also analyzed for the detection of Salmonella, Shigella, Campylobacter, and Vibrio species. The stool was not analyzed for enteric viruses. Abstract . Diarrhea is still a prevalent health issue in HIV patients. Our objective was to characterize the different diarrheagenic E. coli (DEC) groups in stools from adult HIV patients. Cross sectional study: We enrolled HIV-positive and -negative patients with and without diarrhea from a tertiary-care center of Lima, Peru. Clinical data was recorded and a stool sample per patient was cultured. Multiplex PCR was used to detect different DECs. One hundred eighty-four participants were enrolled. The frequency of having at least one DEC was more common in HIV-positive than HIV-negative patients with diarrhea (42% versus 20%, P < 0.05). The enterotoxigenic E. coli (ETEC) was the most common DEC in patients with diarrhea, 13% in HIV patients. The diffusely adherent E. coli (DAEC) was only present in HIV positive patients with diarrhea (10.1%). Different types of DEC are frequent in stools from HIV-positive patients.
METHODS

Ninety of 114 HIV
+ patients had a CD4 count measured between 90 days before and after the stool sample was taken. There were no statistical differences in the frequency of DECs between those who had ≥ 200 and < 200 cells/mm 3 ( Table 2 ).
In the HIV + D + group, 36/69 (52.2%) had persistent diarrhea (14 days or more) when they were enrolled. The frequency of having at least one DEC was higher in patients who had persistent diarrhea (50% versus 33%) ( Table 3 ) .
DISCUSSION
We found a high frequency of DEC in HIV + D + patients but also in HIV + D − individuals using a high sensitivity and specificity method for E. coli pathotypes detection. 3 Colonization with enteric pathogens is common in other populations, such as children from developing countries. 5, 6 A complex relationship between factors related to the host (cell immunosuppresion), the bacterial agent, and the environment (high frequency of exposure to enteric pathogens caused by fecal contamination of water and food) may be responsible for the enteric pathogen colonization in HIV individuals from developing countries.
The ETEC is a well-recognized diarrheal agent among children in the developing world and in travelers, − patients. In a previous study in Lima, Cárcamo and others 9 found ETEC in 4% of AIDS patients with diarrhea (but using a different technique).
The EAEC is also related to diarrheal diseases in small children and is a leading pathogen in travelers' diarrhea. 8, 10 Previous studies have shown a strong correlation between EAEC and AIDS patients with diarrhea. 1 We found EAEC in HIV + D + but we also found a higher frequency of EAEC in patients without diarrhea. This rate of EAEC colonization in HIV + patients could be related to the factors described previously. The role of DAEC in HIV-associated diarrhea has not been adequately studied. Of interest, in this study we found DAEC only in the group of HIV patients with diarrhea. There are very few studies that have looked at the prevalence of DAEC in HIV patients, therefore it is important to replicate this study to confirm this unique finding. The role of DAEC in diarrheal disease has been controversial because some studies reported similar frequency of isolation from diarrhea and control samples. However, other case-control studies have found a correlation between DAEC infection and diarrhea, especially in children > 12 months of age. 11, 12 In a recent diarrhea cohort study in infants from peri-urban communities of Lima we found that although DAEC accounted for only 5% of the cases, it was significantly associated with diarrhea in infants 6-12 months of age. 13 The DAEC strains are identified on the basis of their diffuse adherence pattern on cultured epithelial cells. One of the adherence factors of DAEC is the surface fimbriae that are responsible for the diffuse adherence phenotype in a prototype strain. These fimbriae are homologous with members of the Afa/Dr family of adhesins, 14 which are identified by hybridization to specific probes, daaC or daaD , common to operons encoding Afa/Dr adhesions. The gene used in our multiplex PCR ( daaD) is for an initial screening of DAED strains. Other virulence markers may be worth studying to further define more virulent strains.
The main limitation of this study is the small number of patients included in each subgroup and that the HIV status was undocumented in some control patients. Furthermore, the duration of diarrhea episodes were different in both groups being longer in HIV + patients. We conclude that different types of DEC are frequent in stools from HIV + patients with and without diarrhea regardless of the duration of diarrheal episode and immunity status. Further studies with a higher number of participants should be done to evaluate the role of the different DEC pathotypes in AIDS patients from Latin America.
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